Abstract
This document provides a summary of the Dutch S3-guidelines on the treatment of psoriasis. These guidelines were finalized in December 2011 and contain unique chapters on the treatment of psoriasis of the face and flexures, childhood psoriasis as well as the patient's perspective on treatment. They also cover the topical treatment of psoriasis, photo(chemo)therapy, conventional systemic therapy and biological therapy.
MeSH terms
-
Adult
-
Anti-Inflammatory Agents / therapeutic use
-
Antibodies, Monoclonal / therapeutic use
-
Biological Products / therapeutic use
-
Child
-
Combined Modality Therapy
-
Contraindications
-
Drug Administration Routes
-
Drug Administration Schedule
-
Drug Interactions
-
Drug Therapy, Combination
-
Humans
-
Immunosuppressive Agents / therapeutic use
-
Netherlands
-
Patient Acceptance of Health Care
-
Psoriasis / drug therapy
-
Psoriasis / radiotherapy
-
Psoriasis / therapy*
-
Retinoids / therapeutic use
-
Ultraviolet Therapy / adverse effects
-
Ultraviolet Therapy / economics
Substances
-
Anti-Inflammatory Agents
-
Antibodies, Monoclonal
-
Biological Products
-
Immunosuppressive Agents
-
Retinoids